Suling W J, Rice L S, Shannon W M
J Natl Cancer Inst. 1983 Apr;70(4):767-9.
The mechanism for an enhanced effect of Aroclor 1254-induced Sprague-Dawley rat liver 9,000 x g supernatant (S9) microsome preparation on the mutagenicity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-N-nitrosourea (CCNU), and 2-[3-(2-chloroethyl)-3-nitrosoureido]-2-deoxy-D-glucopyranose (chlorozotocin) for Salmonella typhimurium strain TA1535 was studied. Although all three compounds were direct-acting mutagens, rat liver S9 increased the mutagenic response to BCNU, CCNU, and chlorozotocin. The enhanced mutagenic effect was independent of NADPH. Heat-denatured S9 enhanced the mutagenicity of BCNU and CCNU, but not that of chlorozotocin. Mutagenic enhancement, however, was less than that observed with untreated S9. The substitution of extractable S9 lipid and bovine serum albumin for S9 in the reaction mixture resulted in an enhanced mutagenicity of CCNU with little or no effect on BCNU or chlorozotocin mutagenicity. These results suggest that the enhanced mutagenicity of CCNU, and possibly that of BCNU, in the presence of S9 was due in part to nonspecific factors that are present in the S9 preparation.
研究了多氯联苯混合物1254诱导的斯普拉格-道利大鼠肝脏9000×g上清液(S9)微粒体制剂对1,3-双(2-氯乙基)-1-亚硝基脲(卡莫司汀)、1-(2-氯乙基)-3-环己基-N-亚硝基脲(洛莫司汀)和2-[3-(2-氯乙基)-3-亚硝基脲基]-2-脱氧-D-吡喃葡萄糖(氯脲霉素)对鼠伤寒沙门氏菌TA1535菌株诱变性增强作用的机制。尽管这三种化合物都是直接作用的诱变剂,但大鼠肝脏S9增加了对卡莫司汀、洛莫司汀和氯脲霉素的诱变反应。增强的诱变作用与烟酰胺腺嘌呤二核苷酸磷酸(NADPH)无关。热变性的S9增强了卡莫司汀和洛莫司汀的诱变性,但未增强氯脲霉素的诱变性。然而,诱变增强作用小于未处理的S9所观察到的。在反应混合物中用可提取的S9脂质和牛血清白蛋白替代S9,导致洛莫司汀的诱变性增强,而对卡莫司汀或氯脲霉素的诱变性几乎没有影响。这些结果表明,在S9存在下,洛莫司汀以及可能卡莫司汀的诱变性增强部分归因于S9制剂中存在的非特异性因素。